Pair Name | Curcumol, TNF-related apoptosis inducing ligand | ||
Phytochemical Name | Curcumol (PubChem CID: 14240392 ) | ||
Anticancer drug Name | TNF-related apoptosis inducing ligand (PubChem CID: / ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Curcumol, TNF-related apoptosis inducing ligand | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Biological Phenomena | Induction-->ROS generation | |||
Gene Regulation | Up-regulation | Cleavage | CASP3 | hsa836 |
Down-regulation | Expression | NQO2 | hsa4835 | |
Up-regulation | Cleavage | PARP1 | hsa142 | |
In Vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_0023 |
NCI-H1299 | Lung large cell carcinoma | Homo sapiens (Human) | CVCL_0060 | |
NCI-H1975 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_1511 | |
NCI-H358 | Minimally invasive lung adenocarcinoma | Homo sapiens (Human) | CVCL_1559 | |
NCI-H460 | Lung large cell carcinoma | Homo sapiens (Human) | CVCL_0459 | |
In Vivo Model | BALB/c nude mice (5-week-old) were subcutaneously inoculated with A549 cells (1×10⁶) | |||
Result | This study characterizes the functional role of NQO2 in TRAIL resistance and the sensitizing function of curcumol by directly targeting NQO2, highlighting the potential of using curcumol as an NQO2 inhibitor for clinical treatment of TRAIL-resistant cancers. |
No. | Title | Href |
---|---|---|
1 | Curcumol Overcomes TRAIL Resistance of Non-Small Cell Lung Cancer by Targeting NRH:Quinone Oxidoreductase 2 (NQO2). Adv Sci (Weinh). 2020 Oct 15;7(22):2002306. doi: 10.1002/advs.202002306. | Click |